NOVOSEVEN
5MG(250KIU) INJ PSO LQF 1+1X5ML III
SÚKL code | 0194242 |
---|---|
Name of the product | NOVOSEVEN |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | NOVOSEVEN |
Supplement | 5MG(250KIU) INJ PSO LQF 1+1X5ML III |
Strenght | 5MG(250KIU) |
Pharmaceutical form | Powder and solvent for solution for injection |
Package | 1+1X5ML III |
Route | Intravenous use |
Wrap type | Vial |
Legal status | na lékařský předpis |
Active substance | EPTACOG ALFA (ACTIVATED) (EPTACOGUM ALFA (ACTIVATUM)) |
ATC group | B02BD08 |
ATC group name | KOAGULAČNÍ FAKTOR VIIA |
Doping | Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
Registration Number | EU/1/96/006/010 |
---|---|
Type of MA | centralised without orphans |
MA status | R - active MA/authorised medicinal product |
MA Holder | Novo Nordisk A/S, Bagsvaerd |
MA Holder country | DÁNSKO |